| Year |
Citation |
Score |
| 2023 |
Huang HC, Guadamuz JS, Hoskins KF, Ko NY, Calip GS. Risk of contralateral breast cancer among Asian/Pacific Islander women in the United States. Breast Cancer Research and Treatment. PMID 37897647 DOI: 10.1007/s10549-023-07140-6 |
0.318 |
|
| 2022 |
Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast (Edinburgh, Scotland). 64: 19-28. PMID 35468476 DOI: 10.1016/j.breast.2022.04.005 |
0.316 |
|
| 2022 |
Wang X, Cho-Phan CD, Hoskins KF, Calip GS. Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 31: 704-706. PMID 35373264 DOI: 10.1158/1055-9965.EPI-22-0066 |
0.324 |
|
| 2022 |
Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes & Control : Ccc. PMID 35226243 DOI: 10.1007/s10552-022-01561-2 |
0.308 |
|
| 2021 |
Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Research and Treatment. PMID 34241741 DOI: 10.1007/s10549-021-06323-3 |
0.306 |
|
| 2020 |
Calip GS, Kidd J, Bernhisel R, Cox HC, Saam J, Rauscher GH, Lancaster JM, Hoskins KF. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling. Breast Cancer Research and Treatment. PMID 32918117 DOI: 10.1007/S10549-020-05922-W |
0.399 |
|
| 2020 |
Mukand NH, Zolekar A, Ko NY, Calip GS. Risks of second primary gynecologic cancers following ovarian cancer treatment in Asian ethnic subgroups in the United States, 2000-2016. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32856609 DOI: 10.1158/1055-9965.Epi-20-0095 |
0.368 |
|
| 2020 |
Zhou J, Calip GS, Rowan S, McGregor JC, Perez RI, Evans CT, Gellad WF, Suda KJ. Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data. Pharmacotherapy. PMID 32767780 DOI: 10.1002/Phar.2452 |
0.314 |
|
| 2020 |
Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Perreira KM, Calip GS, Nutescu EA, Gallo LC, Castaneda SF, Gonzalez F, Qato DM. Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017). American Journal of Public Health. e1-e8. PMID 32673107 DOI: 10.2105/Ajph.2020.305745 |
0.345 |
|
| 2020 |
Sweiss K, Calip GS, Holden J, Lewkowski P, Mialik I, Johnson J, Galvin JP, Rondelli D, Patel P. Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155220927436. PMID 32493164 DOI: 10.1177/1078155220927436 |
0.322 |
|
| 2020 |
Nabulsi NA, Alobaidi A, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes & Control : Ccc. PMID 32356139 DOI: 10.1007/S10552-020-01305-0 |
0.334 |
|
| 2020 |
Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin S, Cahill K, Konig H, Esen A, Shergill A, Odenike O, Stock W, Quigley JG. A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia. American Journal of Hematology. PMID 32311140 DOI: 10.1002/Ajh.25838 |
0.301 |
|
| 2020 |
Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato DM. Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016. Circulation. Cardiovascular Quality and Outcomes. 13: e006215. PMID 32151148 DOI: 10.1161/Circoutcomes.119.006215 |
0.302 |
|
| 2020 |
Kaplan HG, Calip GS, Malmgren JA. Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders. The Oncologist. PMID 32073195 DOI: 10.1634/Theoncologist.2019-0099 |
0.408 |
|
| 2020 |
Calip GS, Patel PR, Sweiss K, Wu Z, Zhou J, Asfaw AA, Adimadhyam S, Lee TA, Chiu BC. Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma. International Journal of Cancer. PMID 31997371 DOI: 10.1002/Ijc.32891 |
0.343 |
|
| 2020 |
Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. Jama Oncology. PMID 31917398 DOI: 10.1001/Jamaoncol.2019.5672 |
0.419 |
|
| 2020 |
Zhou J, Asfaw AA, Nabulsi NA, Mukand NA, Lee I, Ko NY, Boudreau DM, Calip GS. HSR20-113: Diabetes Complications and Risks of Breast Cancer Recurrence Among Older Women Journal of the National Comprehensive Cancer Network. 18: HSR20-113. DOI: 10.6004/Jnccn.2019.7475 |
0.633 |
|
| 2020 |
Calip GS, Law EH, Hubbard C, Nabulsi NA, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D. Metastatic-free intervals and risk of breast cancer-specific mortality among patients with hormone receptor-positive breast cancer: A population-based analysis from the Surveillance, Epidemiology, and End Results registries. Journal of Clinical Oncology. 38: e13034-e13034. DOI: 10.1200/Jco.2020.38.15_Suppl.E13034 |
0.466 |
|
| 2020 |
Calip GS, Hubbard C, Nabulsi NA, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Law EH. Real-world patterns of treatment and recurrence by frailty status among older women with HR-positive, HER2-negative early breast cancer. Journal of Clinical Oncology. 38: 535-535. DOI: 10.1200/Jco.2020.38.15_Suppl.535 |
0.478 |
|
| 2020 |
Calip GS, Ko NY, Sweiss KI, Patel PR, Chiu BC-. Abstract PR09: Racial disparities in health insurance status of U.S. adults with hematologic malignancies in states with and without Medicaid expansion: Analyses from the National Cancer Database, 2007-2016 Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Pr09 |
0.331 |
|
| 2020 |
Mukand NH, Zolekar AN, Ko NY, Calip GS. Abstract C020: Racial differences in the risks of second primary gynecologic cancers following chemotherapy for malignant ovarian tumors: Asian subgroups in the United States, 2000-2016 Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C020 |
0.333 |
|
| 2020 |
Zolekar A, Nabulsi NA, Asfaw AA, Zhou J, Sweiss K, Patel PR, Chiu BC-, Nutescu EA, Calip GS. Abstract 5748: Declines in health-related quality of life among older patients diagnosed with hematologic malignancies Cancer Research. 80: 5748-5748. DOI: 10.1158/1538-7445.Am2020-5748 |
0.392 |
|
| 2020 |
McCormick C, Ko N, Calip G. MC3 DISPARITIES IN HEALTH INSURANCE STATUS AMONG YOUNG ADULT CANCER PATIENTS IN STATES WITH AND WITHOUT MEDICAID EXPANSION: ANALYSES OF THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS REGISTRIES, 2007 - 2016 Value in Health. 23: S7. DOI: 10.1016/J.Jval.2020.04.037 |
0.351 |
|
| 2020 |
Sweiss K, Calip G, Johnson J, Galvin JP, Rondelli D, Patel P. Low Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Receiving Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan Conditioning Biology of Blood and Marrow Transplantation. 26: S153-S154. DOI: 10.1016/J.Bbmt.2019.12.705 |
0.33 |
|
| 2019 |
Guadamuz JS, Ozenberger K, Qato DM, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss K, Patel PR, Chiu BC, Calip GS. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine. 98: e17960. PMID 31725657 DOI: 10.1097/Md.0000000000017960 |
0.367 |
|
| 2019 |
Malmgren JA, Calip GS, Atwood MK, Mayer M, Kaplan HG. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011. Cancer. PMID 31639221 DOI: 10.1002/Cncr.32531 |
0.405 |
|
| 2019 |
Sweiss K, Lee J, Mahmud N, Calip GS, Park Y, Mahmud D, Rondelli D, Patel PR. Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant. Bone Marrow Transplantation. PMID 31527821 DOI: 10.1038/S41409-019-0681-3 |
0.332 |
|
| 2019 |
Sweiss K, Calip GS, Johnson JJ, Rondelli D, Patel PR. Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma. Bone Marrow Transplantation. PMID 31388085 DOI: 10.1038/S41409-019-0628-8 |
0.324 |
|
| 2019 |
Lee I, Adimadhyam S, Nutescu EA, Zhou J, Asfaw AA, Sweiss K, Patel PR, Calip GS. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study. Pharmacotherapy. PMID 31332810 DOI: 10.1002/Phar.2310 |
0.316 |
|
| 2019 |
Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155219851550. PMID 31189419 DOI: 10.1177/1078155219851550 |
0.309 |
|
| 2019 |
Calip GS, Yu O, Boudreau DM, Shao H, Oratz R, Richardson SB, Gold HT. Diabetes and differences in detection of incident invasive breast cancer. Cancer Causes & Control : Ccc. PMID 30949885 DOI: 10.1007/S10552-019-01166-2 |
0.645 |
|
| 2019 |
Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS. Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis. British Journal of Haematology. PMID 30714090 DOI: 10.1111/Bjh.15773 |
0.352 |
|
| 2019 |
Zhou J, Sweiss K, Patel PR, Nutescu E, Ko N, Chiu BC, Calip GS. Adherence and cumulative bisphosphonate dose in relation to risk of skeletal-related events among older patients with multiple myeloma. Journal of Clinical Oncology. 37: e18250-e18250. DOI: 10.1200/Jco.2019.37.15_Suppl.E18250 |
0.384 |
|
| 2019 |
Zhou J, Sweiss K, Patel PR, Nutescu E, Ko N, Chiu BC, Calip GS. Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma. Journal of Clinical Oncology. 37: e18165-e18165. DOI: 10.1200/Jco.2019.37.15_Suppl.E18165 |
0.37 |
|
| 2019 |
Ko N, Hong S, Winn R, Calip GS. Insurance status and racial disparities in detection of early-stage breast cancer. Journal of Clinical Oncology. 37: e18121-e18121. DOI: 10.1200/Jco.2019.37.15_Suppl.E18121 |
0.433 |
|
| 2019 |
Sweiss K, Calip GS, Galvin JP, Rondelli D, Patel P. High Rates of Varicella Zoster Virus Antibody Seroconversion after Administration of the Adjuvanted, Recombinant Varicella Zoster Vaccine in Multiple Myeloma Patients Undergoing Active Treatment Blood. 134: 3081-3081. DOI: 10.1182/Blood-2019-131914 |
0.3 |
|
| 2019 |
Sweiss K, Calip GS, Johnson J, Holden J, Lewkowski P, Mialik I, Galvin JP, Rondelli D, Patel P. Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Undergoing a Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine and Melphalan Blood. 134: 1980-1980. DOI: 10.1182/Blood-2019-131886 |
0.346 |
|
| 2019 |
Gross AE, Suda KJ, Zhou J, Calip G, Rowan SA, Hershow R, Perez R, Evans CT, McGregor JC. 1895. Serious Antibiotic-Related Adverse Effects Following Unnecessary Dental Prophylaxis in the United States Open Forum Infectious Diseases. 6: S56-S56. DOI: 10.1093/Ofid/Ofz359.122 |
0.349 |
|
| 2019 |
Asfaw A, Talon B, Nabulsi N, Alobaidi A, Zhou J, Sweiss K, Patel P, Chiu B, Calip G. PCN175 DEPRESSIVE SYMPTOMS AND RISK OF CANCER-SPECIFIC MORTALITY AMONG OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA: ANALYSES FROM THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) MEDICARE HEALTH OUTCOMES SURVEY (MHOS) Value in Health. 22: S89. DOI: 10.1016/J.Jval.2019.04.297 |
0.357 |
|
| 2019 |
Coleman C, Lee I, Nutescu E, Sweiss K, Patel P, Chiu B, Calip G. PCN161 RISK OF VENOUS THROMBOEMBOLISM ASSOCIATED WITH INITIATION OF CHEMO-IMMUNOTHERAPY AMONG OLDER PATIENTS WITH NON-HODGKIN LYMPHOMA: DIFFERENCES BY RACE AND SUBTYPE Value in Health. 22: S86. DOI: 10.1016/J.Jval.2019.04.285 |
0.344 |
|
| 2019 |
Sweiss K, Calip G, Rondelli D, Patel P. Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Progression Free Survival in Patients with Myeloma Undergoing Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S409. DOI: 10.1016/J.Bbmt.2018.12.828 |
0.322 |
|
| 2018 |
Sweiss K, Calip GS, Oh AL, Rondelli D, Patel PR. Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplantation. PMID 30604772 DOI: 10.1038/S41409-018-0361-8 |
0.345 |
|
| 2018 |
Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. PMID 30548485 DOI: 10.1002/Cncr.31914 |
0.301 |
|
| 2018 |
Zhou J, Han J, Nutescu EA, Patel PR, Sweiss K, Calip GS. Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A Six-Year Propensity Score-Matched Cohort Study. Pharmacotherapy. PMID 30485471 DOI: 10.1002/Phar.2197 |
0.305 |
|
| 2018 |
Zueger PM, Holmes HM, Qato DM, Pickard AS, Calip GS, Lee TA. Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients: A Matched Cohort Analysis. Medical Care. PMID 30363022 DOI: 10.1097/Mlr.0000000000001008 |
0.325 |
|
| 2018 |
Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Risk of Amputations Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study. Diabetes, Obesity & Metabolism. PMID 29971914 DOI: 10.1111/Dom.13459 |
0.303 |
|
| 2018 |
Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study. British Journal of Haematology. PMID 29767446 DOI: 10.1111/Bjh.15396 |
0.347 |
|
| 2018 |
Calip GS, Patel PR, Adimadhyam S, Xing S, Wu Z, Sweiss K, Schumock GT, Lee TA, Chiu BC. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions. International Journal of Cancer. PMID 29603214 DOI: 10.1002/Ijc.31407 |
0.373 |
|
| 2018 |
Zhou J, Calip GS, Nutescu EA. A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism Blood. 132: 3568-3568. DOI: 10.1182/Blood-2018-99-119286 |
0.369 |
|
| 2018 |
Zhou J, Han J, Nutescu EA, Galanter W, Walton SM, Gordeuk VR, Saraf SL, Srisuwananukorn A, Calip GS. Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts Blood. 132: 4817-4817. DOI: 10.1182/Blood-2018-99-119039 |
0.389 |
|
| 2018 |
Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P. Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays Blood. 132: 3542-3542. DOI: 10.1182/Blood-2018-99-117657 |
0.373 |
|
| 2018 |
Sweiss K, Calip GS, Johnson J, Jeong H, Rondelli D, Patel P. Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Treatment Free Survival in Patients with Myeloma Receiving Mel200 and Autologous Stem Cell Transplantation Blood. 132: 4621-4621. DOI: 10.1182/Blood-2018-99-117623 |
0.334 |
|
| 2018 |
Lee I, Adimadhyam S, Nutescu EA, Sweiss K, Patel P, Calip GS. Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas Blood. 132: 2280-2280. DOI: 10.1182/Blood-2018-99-116938 |
0.409 |
|
| 2018 |
Calip GS, Zhou J, Sweiss K, Patel P, Asfaw AA, Lee T, Chiu BC, Nutescu EA. Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma Blood. 132: 4693-4693. DOI: 10.1182/Blood-2018-99-116867 |
0.418 |
|
| 2018 |
Calip GS, Sweiss K, Adimadhyam S, Asfaw AA, Zhou J, Wu Z, Lee T, Chiu BC, Patel P. Biologic Disease-Modifying Antirheumatic Drugs and Risk of Multiple Myeloma Blood. 132: 1888-1888. DOI: 10.1182/Blood-2018-99-116412 |
0.379 |
|
| 2018 |
Malmgren J, Calip G, Atwood M, Kaplan H. Abstract P6-08-11: Regional variation in de novo metastatic breast cancer survival improvement over time using an institutional registry to support SEER analysis: 1990-2010 Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-08-11 |
0.424 |
|
| 2018 |
Moran KM, Wu Z, Adimadhyam S, Lee TA, Chiu BC, Calip GS. Abstract 4225: Myelodysplastic syndrome and acute myeloid leukemia following use of chemo-immunotherapy and granulocyte colony-stimulating factors among elderly non-Hodgkin lymphoma patients Epidemiology. 78: 4225-4225. DOI: 10.1158/1538-7445.Am2018-4225 |
0.402 |
|
| 2017 |
Abhyankar N, Hoskins KF, Abern MR, Calip GS. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis. Bmc Cancer. 17: 659. PMID 28946846 DOI: 10.1186/S12885-017-3640-7 |
0.395 |
|
| 2017 |
Calip GS, Adimadhyam S, Xing S, Rincon JC, Lee WJ, Anguiano RH. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. Seminars in Arthritis and Rheumatism. PMID 28410817 DOI: 10.1016/J.Semarthrit.2017.03.010 |
0.302 |
|
| 2017 |
Wirtz HS, Calip GS, Buist DS, Gralow JR, Barlow WE, Gray S, Boudreau DM. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. American Journal of Epidemiology. 1-12. PMID 28338879 DOI: 10.1093/Aje/Kww242 |
0.764 |
|
| 2017 |
Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer. Journal of Oncology Practice. JOP2016018317. PMID 28287854 DOI: 10.1200/Jop.2016.018317 |
0.421 |
|
| 2017 |
Calip GS, Exten KR, Rauscher GH, Brown K, Bernhisel R, Kidd J, Saam J, Lancaster J, Hoskins K. Family history of breast cancer in non-BRCA male breast cancer: A case-control study. Journal of Clinical Oncology. 35: e13032-e13032. DOI: 10.1200/Jco.2017.35.15_Suppl.E13032 |
0.401 |
|
| 2017 |
Brown K, Calip GS, Bernhisel R, Evans B, Rosenthal ET, Saam J, Lancaster J, Hoskins K. Multi-gene hereditary cancer testing among men with breast cancer. Journal of Clinical Oncology. 35: 1532-1532. DOI: 10.1200/Jco.2017.35.15_Suppl.1532 |
0.324 |
|
| 2017 |
Sweiss K, Oh A, Calip G, Rondelli D, Patel PR. Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era Biology of Blood and Marrow Transplantation. 23: S144. DOI: 10.1182/Blood.V128.22.4631.4631 |
0.352 |
|
| 2016 |
Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Research and Treatment. PMID 27826756 DOI: 10.1007/S10549-016-4043-1 |
0.646 |
|
| 2016 |
Malmgren JA, Calip GS, Pyott SM, Atwood MK, Kaplan HG. Therapy-related myelodysplastic syndrome following primary breast cancer. Leukemia Research. 47: 178-184. PMID 27414978 DOI: 10.1016/J.Leukres.2016.06.005 |
0.381 |
|
| 2016 |
Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study. Cancer Causes & Control : Ccc. PMID 27053250 DOI: 10.1007/S10552-016-0744-3 |
0.651 |
|
| 2016 |
Solanki PA, Ko NY, Qato DM, Calip GS. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011. Springerplus. 5: 82. PMID 26844029 DOI: 10.1186/S40064-016-1726-3 |
0.372 |
|
| 2016 |
Calip GS, Adimadhyam S, Patel PR, Sweiss K, Cha AB, Nagy BJ, Moran KM, Smith SM, Chiu BC. Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma Blood. 128: 841-841. DOI: 10.1182/Blood.V128.22.841.841 |
0.405 |
|
| 2016 |
Adimadhyam S, Sweiss K, Patel PR, Chiu BC, Calip GS. Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma Blood. 128: 2071-2071. DOI: 10.1182/Blood.V128.22.2071.2071 |
0.397 |
|
| 2016 |
Abhyankar N, Hoskins K, Abern M, Calip G. PD09-08 SHOULD A MAN WITH A HISTORY OF BREAST CANCER BE SCREENED FOR PROSTATE CANCER? Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2903 |
0.336 |
|
| 2015 |
Calip GS, Malmgren JA, Lee WJ, Schwartz SM, Kaplan HG. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer. Breast Cancer Research and Treatment. PMID 26450505 DOI: 10.1007/S10549-015-3590-1 |
0.458 |
|
| 2015 |
Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Breast Cancer Research and Treatment. 151: 687-96. PMID 26012645 DOI: 10.1200/Jco.2015.33.15_Suppl.E12592 |
0.411 |
|
| 2015 |
Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes & Control : Ccc. 26: 1065-77. PMID 25956271 DOI: 10.1007/S10552-015-0599-Z |
0.64 |
|
| 2015 |
Kaplan HG, Malmgren JA, Atwood MK, Calip GS. Effect of treatment and mammography detection on breast cancer survival over time: 1990-2007. Cancer. 121: 2553-61. PMID 25872471 DOI: 10.1002/Cncr.29371 |
0.395 |
|
| 2015 |
Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiology and Drug Safety. 24: 75-85. PMID 24923811 DOI: 10.1002/Pds.3660 |
0.632 |
|
| 2015 |
Calip GS, Law E, Lee W, Schwartz S, Ko N. Differences in comorbidity at diagnosis and receipt of adjuvant chemotherapy among older women by race and ethnicity. Journal of Clinical Oncology. 33: e17599-e17599. DOI: 10.1200/Jco.2015.33.15_Suppl.E17599 |
0.405 |
|
| 2015 |
Chiu BC, Chen J, Yen Y, Calip GS, Chien C, Ahsan H, Shih YT, Cheng K. Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study Blood. 126: 4198-4198. DOI: 10.1182/Blood.V126.23.4198.4198 |
0.359 |
|
| 2015 |
Calip GS, Lee W, Lee TA, Schumock GT, Chiu BC. Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma Blood. 126: 2954-2954. DOI: 10.1182/Blood.V126.23.2954.2954 |
0.324 |
|
| 2015 |
Calip GS, Lee W, Lee TA, Schumock GT, Chiu BC. Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors Blood. 126: 2653-2653. DOI: 10.1182/Blood.V126.23.2653.2653 |
0.318 |
|
| 2015 |
Calip GS, Boudreau DM. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd4-6 |
0.654 |
|
| 2015 |
Calip G, Malmgren J, Atwood M, Kaplan H. 77 MYELODYSPLASTIC SYNDROME FOLLOWING PRIMARY BREAST CANCER TREATMENT: CASES FROM A COMMUNITY CANCER CENTER, 1990-2014 Leukemia Research. 39: S37-S38. DOI: 10.1016/S0145-2126(15)30078-3 |
0.38 |
|
| 2015 |
Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors Breast Cancer Research and Treatment. 151: 687-696. DOI: 10.1007/s10549-015-3439-7 |
0.308 |
|
| 2014 |
Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Research and Treatment. 148: 363-77. PMID 25301086 DOI: 10.1007/S10549-014-3157-6 |
0.644 |
|
| 2013 |
Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast Cancer Research and Treatment. 142: 629-36. PMID 24265034 DOI: 10.1007/S10549-013-2773-X |
0.369 |
|
| 2013 |
Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Research and Treatment. 138: 225-33. PMID 23358904 DOI: 10.1007/S10549-013-2424-2 |
0.65 |
|
| 2013 |
Kaplan HG, Malmgren JA, Calip GS, Li C. MDS/AML risk post-breast cancer and association with age: SEER data 2001-2009. Journal of Clinical Oncology. 31: 554-554. DOI: 10.1200/Jco.2013.31.15_Suppl.554 |
0.411 |
|
| 2012 |
Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 176: 156-63. PMID 22759721 DOI: 10.1093/Aje/Kwr524 |
0.355 |
|
| Show low-probability matches. |